Lorraine B Ware1, Jason D Christie2,3, Joshua M Diamond2, Mary K Porteous2, L Jackson Roberts4, Nancy Wickersham5, Melanie Rushefski2, Steven M Kawut2,3,6, Rupal J Shah7, Edward Cantu8, David J Lederer9, Shampa Chatterjee10, Vibha N Lama11, Sangeeta Bhorade12, Maria Crespo13, John McDyer13, Keith Wille14, Jonathan Orens15, Ann Weinacker16, Selim Arcasoy9, Pali D Shah15, David S Wilkes17, Chadi Hage17, Scott M Palmer18, Laurie Snyder18, Carolyn S Calfee7,19. 1. Departments of Medicine and Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee. 2. Pulmonary, Allergy, and Critical Care Division, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. 3. Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Philadelphia, PA. 4. Departments of Medicine and Pharmacology, Vanderbilt University, Nashville, Tennessee. 5. Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University, Nashville, Tennessee. 6. Penn Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. 7. Department of Medicine, University of California, San Francisco, California. 8. Division of Cardiovascular Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA. 9. Division of Pulmonary, Allergy, and Critical Care Medicine, Columbia University College of Physicians and Surgeons, New York, New York. 10. Department of Physiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Philadelphia, PA. 11. Division of Pulmonary, Allergy, and Critical Care Medicine, University of Michigan, Ann Arbor, Michigan. 12. Division of Pulmonary and Critical Care Medicine, Northwestern University, Chicago, Illinois. 13. Division of Pulmonary, Allergy, and Critical Care, University of Pittsburgh, Pittsburgh, Pennsylvania. 14. Division of Pulmonary and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 15. Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Johns Hopkins University Hospital, Baltimore, Maryland. 16. Division of Pulmonary and Critical Care Medicine, Stanford University, Palo Alto, California. 17. Division of Pulmonary, Allergy, Critical Care, and Occupational Medicine, Indiana University School of Medicine, Indianapolis, Indiana. 18. Division of Pulmonary, Allergy, and Critical Care Medicine, Duke University, Raleigh-Durham, North Carolina. 19. Departments of Medicine and Anesthesia, University of California, San Francisco, California.
Abstract
BACKGROUND: Donor smoking history and higher fraction of inspired oxygen (FIO2) at reperfusion are associated with primary graft dysfunction (PGD) after lung transplantation. We hypothesized that oxidative injury biomarkers would be elevated in PGD, with higher levels associated with donor exposure to cigarette smoke and recipient hyperoxia at reperfusion. METHODS: We performed a nested case-control study of 72 lung transplant recipients from the Lung Transplant Outcomes Group cohort. Using mass spectroscopy, F2-isoprostanes and isofurans were measured in plasma collected after transplantation. Cases were defined in 2 ways: grade 3 PGD present at day 2 or day 3 after reperfusion (severe PGD) or any grade 3 PGD (any PGD). RESULTS: There were 31 severe PGD cases with 41 controls and 35 any PGD cases with 37 controls. Plasma F2-isoprostane levels were higher in severe PGD cases compared with controls (28.6 pg/ml vs 19.8 pg/ml, p = 0.03). Plasma F2-isoprostane levels were higher in severe PGD cases compared with controls (29.6 pg/ml vs 19.0 pg/ml, p = 0.03) among patients reperfused with FIO2 >40%. Among recipients of lungs from donors with smoke exposure, plasma F2-isoprostane (38.2 pg/ml vs 22.5 pg/ml, p = 0.046) and isofuran (66.9 pg/ml vs 34.6 pg/ml, p = 0.046) levels were higher in severe PGD compared with control subjects. CONCLUSIONS: Plasma levels of lipid peroxidation products are higher in patients with severe PGD, in recipients of lungs from donors with smoke exposure, and in recipients exposed to higher Fio2 at reperfusion. Oxidative injury is an important mechanism of PGD and may be magnified by donor exposure to cigarette smoke and hyperoxia at reperfusion.
BACKGROUND:Donor smoking history and higher fraction of inspired oxygen (FIO2) at reperfusion are associated with primary graft dysfunction (PGD) after lung transplantation. We hypothesized that oxidative injury biomarkers would be elevated in PGD, with higher levels associated with donor exposure to cigarette smoke and recipient hyperoxia at reperfusion. METHODS: We performed a nested case-control study of 72 lung transplant recipients from the Lung Transplant Outcomes Group cohort. Using mass spectroscopy, F2-isoprostanes and isofurans were measured in plasma collected after transplantation. Cases were defined in 2 ways: grade 3 PGD present at day 2 or day 3 after reperfusion (severe PGD) or any grade 3 PGD (any PGD). RESULTS: There were 31 severe PGD cases with 41 controls and 35 any PGD cases with 37 controls. Plasma F2-isoprostane levels were higher in severe PGD cases compared with controls (28.6 pg/ml vs 19.8 pg/ml, p = 0.03). Plasma F2-isoprostane levels were higher in severe PGD cases compared with controls (29.6 pg/ml vs 19.0 pg/ml, p = 0.03) among patients reperfused with FIO2 >40%. Among recipients of lungs from donors with smoke exposure, plasma F2-isoprostane (38.2 pg/ml vs 22.5 pg/ml, p = 0.046) and isofuran (66.9 pg/ml vs 34.6 pg/ml, p = 0.046) levels were higher in severe PGD compared with control subjects. CONCLUSIONS: Plasma levels of lipid peroxidation products are higher in patients with severe PGD, in recipients of lungs from donors with smoke exposure, and in recipients exposed to higher Fio2 at reperfusion. Oxidative injury is an important mechanism of PGD and may be magnified by donor exposure to cigarette smoke and hyperoxia at reperfusion.
Authors: R J Shah; J M Diamond; E Cantu; J Flesch; J C Lee; D J Lederer; V N Lama; J Orens; A Weinacker; D S Wilkes; D Roe; S Bhorade; K M Wille; L B Ware; S M Palmer; M Crespo; E Demissie; J Sonnet; A Shah; S M Kawut; S L Bellamy; A R Localio; J D Christie Journal: Am J Transplant Date: 2015-04-15 Impact factor: 8.086
Authors: Marc de Perrot; Robert S Bonser; John Dark; Rosemary F Kelly; David McGiffin; Rebecca Menza; Octavio Pajaro; Stephan Schueler; Geert M Verleden Journal: J Heart Lung Transplant Date: 2005-08-08 Impact factor: 10.247
Authors: Jason D Christie; Dirk Van Raemdonck; Marc de Perrot; Mark Barr; Shaf Keshavjee; Selim Arcasoy; Jonathan Orens Journal: J Heart Lung Transplant Date: 2005-10 Impact factor: 10.247
Authors: Mark L Barr; Steven M Kawut; Timothy P Whelan; Reda Girgis; Heidi Böttcher; Joshua Sonett; Wickii Vigneswaran; David M Follette; Paul A Corris Journal: J Heart Lung Transplant Date: 2005-07-27 Impact factor: 10.247
Authors: Jason D Christie; Martin Carby; Remzi Bag; Paul Corris; Marshall Hertz; David Weill Journal: J Heart Lung Transplant Date: 2005-06-04 Impact factor: 10.247
Authors: Andrea Porzionato; Maria Martina Sfriso; Andrea Mazzatenta; Veronica Macchi; Raffaele De Caro; Camillo Di Giulio Journal: Respir Physiol Neurobiol Date: 2014-12-06 Impact factor: 1.931
Authors: Krithika Lingappan; Weiwu Jiang; Lihua Wang; Gangduo Wang; Xanthi I Couroucli; Binoy Shivanna; Stephen E Welty; Roberto Barrios; M Firoze Khan; Daniel W Nebert; L Jackson Roberts; Bhagavatula Moorthy Journal: Toxicol Sci Date: 2014-06-03 Impact factor: 4.849
Authors: Jason B Turowski; Ralph A Pietrofesa; John A Lawson; Melpo Christofidou-Solomidou; Denis Hadjiliadis Journal: BMC Complement Altern Med Date: 2015-05-13 Impact factor: 3.659
Authors: Mary K Porteous; James C Lee; David J Lederer; Scott M Palmer; Edward Cantu; Rupal J Shah; Scarlett L Bellamy; Vibha N Lama; Sangeeta M Bhorade; Maria M Crespo; John F McDyer; Keith M Wille; A Russell Localio; Jonathan B Orens; Pali D Shah; Ann B Weinacker; Selim Arcasoy; David S Wilkes; Lorraine B Ware; Jason D Christie; Steven M Kawut; Joshua M Diamond Journal: Ann Am Thorac Soc Date: 2017-10
Authors: Michaela R Anderson; Ethan A Edwin; Joshua M Diamond; Anthony Ferrante; Joshua Sonett; Frank D'Ovidio; Selim Arcasoy; Edward Cantu; Jason D Christie; David J Lederer Journal: Am J Respir Cell Mol Biol Date: 2019-08 Impact factor: 6.914
Authors: Ciara M Shaver; Nancy Wickersham; J Brennan McNeil; Hiromasa Nagata; Adam Miller; Stuart R Landstreet; Jamie L Kuck; Joshua M Diamond; David J Lederer; Steven M Kawut; Scott M Palmer; Keith M Wille; Ann Weinacker; Vibha N Lama; Maria M Crespo; Jonathan B Orens; Pali D Shah; Chadi A Hage; Edward Cantu; Mary K Porteous; Gundeep Dhillon; John McDyer; Julie A Bastarache; Jason D Christie; Lorraine B Ware Journal: JCI Insight Date: 2018-01-25
Authors: Michaela R Anderson; Jayaram K Udupa; Ethan Edwin; Joshua M Diamond; Jonathan P Singer; Jasleen Kukreja; Steven R Hays; John R Greenland; Anthony Ferrante; Matthew Lippel; Tatiana Blue; Amika McBurnie; Michelle Oyster; Laurel Kalman; Melanie Rushefski; Caiyun Wu; Gargi Pednekar; Wen Liu; Selim Arcasoy; Joshua Sonett; Frank D'Ovidio; Matthew Bacchetta; John D Newell; Drew Torigian; Edward Cantu; Donna L Farber; Jon T Giles; Yubing Tong; Scott Palmer; Lorraine B Ware; Wayne W Hancock; Jason D Christie; David J Lederer Journal: J Heart Lung Transplant Date: 2019-08-10 Impact factor: 10.247
Authors: Jake G Natalini; Joshua M Diamond; Mary K Porteous; David J Lederer; Keith M Wille; Ann B Weinacker; Jonathan B Orens; Pali D Shah; Vibha N Lama; John F McDyer; Laurie D Snyder; Chadi A Hage; Jonathan P Singer; Lorraine B Ware; Edward Cantu; Michelle Oyster; Laurel Kalman; Jason D Christie; Steven M Kawut; Elana J Bernstein Journal: J Heart Lung Transplant Date: 2021-01-23 Impact factor: 10.247
Authors: Pierre-Hugues Stefanuto; Rosalba Romano; Christiaan A Rees; Mavra Nasir; Louit Thakuria; Andre Simon; Anna K Reed; Nandor Marczin; Jane E Hill Journal: Sci Rep Date: 2022-02-08 Impact factor: 4.379